Mary Elizabeth Cunnane, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neck Dissection | 2 | 2016 | 196 | 0.620 |
Why?
|
| Neuroma, Acoustic | 3 | 2017 | 450 | 0.520 |
Why?
|
| Thyroid Neoplasms | 7 | 2023 | 2274 | 0.480 |
Why?
|
| Thyroid Gland | 3 | 2016 | 1172 | 0.470 |
Why?
|
| Thyroidectomy | 4 | 2023 | 877 | 0.460 |
Why?
|
| Ethmoid Sinus | 2 | 2009 | 58 | 0.420 |
Why?
|
| Orbit | 5 | 2020 | 427 | 0.410 |
Why?
|
| Endoscopy | 7 | 2017 | 1774 | 0.390 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2017 | 770 | 0.350 |
Why?
|
| Ethmoid Bone | 1 | 2009 | 35 | 0.340 |
Why?
|
| Tinnitus | 1 | 2011 | 195 | 0.330 |
Why?
|
| Oculomotor Muscles | 2 | 2020 | 371 | 0.280 |
Why?
|
| Tongue Neoplasms | 2 | 2018 | 179 | 0.280 |
Why?
|
| Cochlea | 2 | 2016 | 828 | 0.280 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3465 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2019 | 20086 | 0.260 |
Why?
|
| Sinusitis | 3 | 2014 | 922 | 0.250 |
Why?
|
| Carcinoma, Papillary | 3 | 2023 | 781 | 0.240 |
Why?
|
| Temporal Bone | 3 | 2017 | 661 | 0.230 |
Why?
|
| Otologic Surgical Procedures | 2 | 2016 | 145 | 0.230 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 11001 | 0.220 |
Why?
|
| Orbital Diseases | 2 | 2016 | 181 | 0.220 |
Why?
|
| Ear, Middle | 2 | 2014 | 332 | 0.200 |
Why?
|
| Graves Ophthalmopathy | 1 | 2020 | 117 | 0.160 |
Why?
|
| Audiometry | 3 | 2017 | 242 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 166 | 0.160 |
Why?
|
| Auditory Brain Stem Implantation | 1 | 2017 | 14 | 0.160 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2017 | 30 | 0.160 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2017 | 54 | 0.150 |
Why?
|
| Glossectomy | 1 | 2017 | 58 | 0.150 |
Why?
|
| Ultrasonography | 5 | 2018 | 5978 | 0.150 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2017 | 116 | 0.150 |
Why?
|
| Round Window, Ear | 1 | 2016 | 47 | 0.140 |
Why?
|
| Mucorales | 1 | 2016 | 33 | 0.140 |
Why?
|
| Mouth Neoplasms | 2 | 2012 | 601 | 0.140 |
Why?
|
| Ear, Inner | 2 | 2017 | 420 | 0.140 |
Why?
|
| Endoscopes | 1 | 2016 | 174 | 0.130 |
Why?
|
| Acrocephalosyndactylia | 1 | 2016 | 89 | 0.130 |
Why?
|
| Intracranial Hypertension | 1 | 2018 | 186 | 0.130 |
Why?
|
| Mucormycosis | 1 | 2016 | 97 | 0.130 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2014 | 14 | 0.130 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2014 | 13 | 0.130 |
Why?
|
| Eye Infections, Fungal | 1 | 2016 | 110 | 0.130 |
Why?
|
| Neck | 2 | 2016 | 693 | 0.120 |
Why?
|
| Orbital Neoplasms | 1 | 2017 | 225 | 0.120 |
Why?
|
| Orbital Fractures | 1 | 2015 | 110 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 2 | 2010 | 885 | 0.120 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2013 | 49 | 0.120 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2015 | 115 | 0.120 |
Why?
|
| Nasal Septum | 1 | 2014 | 127 | 0.110 |
Why?
|
| Maxillary Sinus | 1 | 2014 | 180 | 0.110 |
Why?
|
| Auditory Perception | 1 | 2017 | 568 | 0.110 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2014 | 153 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2019 | 795 | 0.110 |
Why?
|
| Otitis Media with Effusion | 1 | 2013 | 114 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2017 | 484 | 0.110 |
Why?
|
| Paranasal Sinuses | 2 | 2012 | 249 | 0.110 |
Why?
|
| Brain Stem | 1 | 2017 | 844 | 0.110 |
Why?
|
| Intraoperative Period | 2 | 2017 | 520 | 0.100 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2012 | 96 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2013 | 2245 | 0.100 |
Why?
|
| Infratentorial Neoplasms | 1 | 2012 | 94 | 0.100 |
Why?
|
| Laryngectomy | 1 | 2014 | 248 | 0.100 |
Why?
|
| Nasal Polyps | 2 | 2014 | 360 | 0.100 |
Why?
|
| Thyroglossal Cyst | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cochlear Implantation | 1 | 2016 | 310 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2015 | 722 | 0.100 |
Why?
|
| Mouth Floor | 1 | 2011 | 34 | 0.100 |
Why?
|
| Ear Canal | 2 | 2016 | 146 | 0.100 |
Why?
|
| Tongue Diseases | 1 | 2011 | 67 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 847 | 0.100 |
Why?
|
| Paraproteinemias | 1 | 2013 | 247 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2019 | 35342 | 0.090 |
Why?
|
| Dermoid Cyst | 1 | 2011 | 92 | 0.090 |
Why?
|
| Angiofibroma | 1 | 2010 | 68 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2014 | 924 | 0.090 |
Why?
|
| Ethmoid Sinusitis | 1 | 2008 | 25 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 2906 | 0.080 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2008 | 57 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 879 | 0.080 |
Why?
|
| Physical Examination | 1 | 2014 | 1239 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2542 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 763 | 0.080 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2008 | 73 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 57683 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2010 | 285 | 0.080 |
Why?
|
| Rhinitis | 1 | 2014 | 691 | 0.070 |
Why?
|
| Vision Disorders | 2 | 2018 | 1057 | 0.070 |
Why?
|
| Vestibular Aqueduct | 1 | 2007 | 66 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2008 | 166 | 0.070 |
Why?
|
| Aged | 15 | 2017 | 162944 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 1009 | 0.070 |
Why?
|
| Radiography | 2 | 2011 | 7010 | 0.070 |
Why?
|
| Thyroid Nodule | 1 | 2013 | 750 | 0.070 |
Why?
|
| Male | 25 | 2017 | 349538 | 0.070 |
Why?
|
| Ear Neoplasms | 1 | 2006 | 117 | 0.070 |
Why?
|
| Cytological Techniques | 1 | 2007 | 219 | 0.070 |
Why?
|
| Disease Management | 1 | 2016 | 2450 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2099 | 0.060 |
Why?
|
| Middle Aged | 18 | 2017 | 213127 | 0.060 |
Why?
|
| Humans | 38 | 2023 | 742088 | 0.060 |
Why?
|
| Adult | 19 | 2018 | 213712 | 0.060 |
Why?
|
| Diagnosis, Differential | 7 | 2018 | 12958 | 0.060 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2008 | 448 | 0.060 |
Why?
|
| Aspirin | 1 | 2016 | 3278 | 0.060 |
Why?
|
| Fibrosis | 1 | 2011 | 2026 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2023 | 77098 | 0.060 |
Why?
|
| Female | 22 | 2019 | 379592 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8925 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 4029 | 0.050 |
Why?
|
| Biopsy | 4 | 2019 | 6756 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2009 | 1484 | 0.050 |
Why?
|
| Patient Selection | 2 | 2017 | 4214 | 0.050 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2002 | 101 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2007 | 1285 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2002 | 150 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4554 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 329 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 4029 | 0.050 |
Why?
|
| Postoperative Period | 2 | 2017 | 1839 | 0.050 |
Why?
|
| Nasal Obstruction | 2 | 2014 | 151 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1183 | 0.050 |
Why?
|
| Contrast Media | 4 | 2013 | 5295 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 2000 | 180 | 0.050 |
Why?
|
| Enema | 1 | 2000 | 141 | 0.050 |
Why?
|
| Thoracic Neoplasms | 1 | 2002 | 268 | 0.040 |
Why?
|
| Young Adult | 5 | 2017 | 56350 | 0.040 |
Why?
|
| Neurofibromatosis 2 | 2 | 2017 | 380 | 0.040 |
Why?
|
| Reoperation | 2 | 2023 | 4200 | 0.040 |
Why?
|
| Glaucoma | 1 | 2008 | 1152 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 1144 | 0.040 |
Why?
|
| Thorax | 1 | 2002 | 547 | 0.040 |
Why?
|
| Biopsy, Needle | 3 | 2011 | 1640 | 0.040 |
Why?
|
| Microsurgery | 2 | 2016 | 796 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2014 | 14720 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1725 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 2018 | 281 | 0.030 |
Why?
|
| Prognosis | 3 | 2014 | 29010 | 0.030 |
Why?
|
| Mouth | 1 | 2018 | 373 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 245 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4554 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 80 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 380 | 0.030 |
Why?
|
| History of Medicine | 1 | 1975 | 35 | 0.030 |
Why?
|
| Foundations | 1 | 1975 | 94 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2023 | 9144 | 0.030 |
Why?
|
| Training Support | 1 | 1975 | 113 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4839 | 0.030 |
Why?
|
| Skull Fractures | 1 | 2015 | 195 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2002 | 2013 | 0.030 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2016 | 349 | 0.030 |
Why?
|
| Biology | 1 | 1975 | 292 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 1333 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 808 | 0.030 |
Why?
|
| Adolescent | 3 | 2016 | 85649 | 0.030 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 112 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 2658 | 0.030 |
Why?
|
| Deafness | 1 | 2016 | 461 | 0.030 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 173 | 0.030 |
Why?
|
| Calcitonin | 1 | 2013 | 336 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2016 | 729 | 0.020 |
Why?
|
| Cochlear Implants | 1 | 2016 | 339 | 0.020 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 324 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 571 | 0.020 |
Why?
|
| Paralysis | 1 | 2012 | 249 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2006 | 3456 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 62966 | 0.020 |
Why?
|
| Morbidity | 1 | 2016 | 1767 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2016 | 450 | 0.020 |
Why?
|
| Carcinoma | 1 | 2002 | 2374 | 0.020 |
Why?
|
| Headache | 1 | 2018 | 1219 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 819 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 20774 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 389 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2013 | 850 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2016 | 765 | 0.020 |
Why?
|
| Enophthalmos | 1 | 2008 | 34 | 0.020 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 325 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2008 | 137 | 0.020 |
Why?
|
| Career Choice | 1 | 1975 | 743 | 0.020 |
Why?
|
| Tongue | 1 | 2011 | 406 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15056 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 1093 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5062 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1849 | 0.020 |
Why?
|
| Iopamidol | 1 | 2007 | 191 | 0.020 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2007 | 60 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2007 | 155 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39004 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15244 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1355 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 1975 | 1066 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2017 | 40955 | 0.020 |
Why?
|
| Hearing Disorders | 1 | 2006 | 125 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2011 | 706 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26343 | 0.020 |
Why?
|
| Mycoses | 1 | 2008 | 376 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 951 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2008 | 378 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9185 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1483 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 8829 | 0.020 |
Why?
|
| Piperidines | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Stroke | 1 | 2007 | 9963 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2008 | 2027 | 0.010 |
Why?
|
| Child | 2 | 2009 | 77478 | 0.010 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2007 | 324 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11363 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3612 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 554 | 0.010 |
Why?
|
| Decision Making | 1 | 1975 | 3869 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 53187 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15530 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2002 | 981 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 24913 | 0.010 |
Why?
|
| ROC Curve | 1 | 2007 | 3528 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14554 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 611 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 19223 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2006 | 1669 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2746 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 4961 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6259 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 5948 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7141 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2502 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35070 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5385 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4434 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5180 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 19862 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 23320 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 81045 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7873 | 0.000 |
Why?
|
| Animals | 1 | 2014 | 168561 | 0.000 |
Why?
|
| United States | 1 | 1975 | 69693 | 0.000 |
Why?
|